Search results
EHA 2024: Brukinsa/Venclexta for CLL/SLL lacks control arm in SEQUOIA trial
Clinical Trials Arena via Yahoo Finance· 4 days agoAt the 2024 Congress of the European Hematology Association (EHA 2024) on 14 June, preliminary...
Lilly (LLY) Gets Second FDA Nod for Lymphoma Drug Jaypirca
Zacks via Yahoo Finance· 7 months agoFollowing the latest approval, Lilly's (LLY) Jaypirca is the first and the only non-covalent BTK...
AbbVie (ABBV), J&J to Withdraw 2 Blood Cancer Nods for Imbruvica
Zacks via Yahoo Finance· 1 year agoAbbVie (ABBV)/J&J's (JNJ) decision to withdraw the FDA's accelerated approval for Imbruvica in two...
Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
Zacks via Yahoo Finance· 3 days agoUpdated data from a clinical study shows that treatment with Mustang Bio's (MBIO) experimental cell...